Lantheus Holdings, Inc. Selling and Marketing Expense
Lantheus Holdings, Inc. (LNTH) reported Selling and Marketing Expense of $82.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-06
- Lantheus Holdings, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $82.81M, a 101.76% increase year-over-year.
- Lantheus Holdings, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $52.68M, a 23.95% increase year-over-year.
- Lantheus Holdings, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $46.32M, a 6.14% increase year-over-year.
- Lantheus Holdings, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $48.83M, a 11.69% increase year-over-year.
- Lantheus Holdings, Inc. selling and marketing expense for fiscal 2025 was $178.69M, a 0.42% increase from fiscal 2024.
- Lantheus Holdings, Inc. selling and marketing expense for fiscal 2024 was $177.94M, a 25.54% increase from fiscal 2023.
- Lantheus Holdings, Inc. selling and marketing expense for fiscal 2023 was $141.74M, a 41.39% increase from fiscal 2022.
- Lantheus Holdings, Inc. selling and marketing expense for fiscal 2022 was $100.24M, a 46.51% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $82.81M 10-Q · filed 2026-08-06 | $135.49M 10-Q · filed 2026-08-06 | $181.81M derived: sum of 3 quarters · filed 2026-08-06 | $230.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $52.68M 10-Q · filed 2026-05-07 | $99.00M derived: sum of 2 quarters · filed 2026-05-07 | $147.83M derived: sum of 3 quarters · filed 2026-05-07 | $188.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $46.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $95.15M derived: sum of 2 quarters · filed 2026-02-26 | $136.19M derived: sum of 3 quarters · filed 2026-08-06 | $178.69M 10-K · filed 2026-02-26 |
| 2025-09-30 | $48.83M 10-Q · filed 2025-11-06 | $89.87M derived: sum of 2 quarters · filed 2026-08-06 | $132.37M 10-Q · filed 2025-11-06 | $176.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $41.04M 10-Q · filed 2026-08-06 | $83.54M 10-Q · filed 2026-08-06 | $127.18M derived: sum of 3 quarters · filed 2026-08-06 | $170.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $42.50M 10-Q · filed 2026-05-07 | $86.14M derived: sum of 2 quarters · filed 2026-05-07 | $129.86M derived: sum of 3 quarters · filed 2026-05-07 | $174.90M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $43.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $87.36M derived: sum of 2 quarters · filed 2026-02-26 | $132.39M derived: sum of 3 quarters · filed 2026-02-26 | $177.94M 10-K · filed 2026-02-26 |
| 2024-09-30 | $43.72M 10-Q · filed 2025-11-06 | $88.75M derived: sum of 2 quarters · filed 2025-11-06 | $134.30M 10-Q · filed 2025-11-06 | $169.56M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $45.03M 10-Q · filed 2025-08-06 | $90.58M 10-Q · filed 2025-08-06 | $125.84M derived: sum of 3 quarters · filed 2026-02-26 | $163.24M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $45.55M 10-Q · filed 2025-05-07 | $80.81M derived: sum of 2 quarters · filed 2026-02-26 | $118.21M derived: sum of 3 quarters · filed 2026-02-26 | $154.66M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $35.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $72.66M derived: sum of 2 quarters · filed 2026-02-26 | $109.12M derived: sum of 3 quarters · filed 2026-02-26 | $141.74M 10-K · filed 2026-02-26 |
| 2023-09-30 | $37.40M 10-Q · filed 2024-11-06 | $73.86M derived: sum of 2 quarters · filed 2024-11-06 | $106.47M 10-Q · filed 2024-11-06 | $133.46M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $36.46M 10-Q · filed 2024-07-31 | $69.07M 10-Q · filed 2024-07-31 | $96.06M derived: sum of 3 quarters · filed 2025-02-26 | $121.47M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $32.62M 10-Q · filed 2024-05-02 | $59.60M derived: sum of 2 quarters · filed 2025-02-26 | $85.01M derived: sum of 3 quarters · filed 2025-02-26 | $112.51M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $26.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $52.40M derived: sum of 2 quarters · filed 2025-02-26 | $79.89M derived: sum of 3 quarters · filed 2025-02-26 | $100.24M 10-K · filed 2025-02-26 |
| 2022-09-30 | $25.41M 10-Q · filed 2023-11-02 | $52.91M derived: sum of 2 quarters · filed 2023-11-02 | $73.26M 10-Q · filed 2023-11-02 | $92.68M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $27.49M 10-Q · filed 2023-08-03 | $47.85M 10-Q · filed 2023-08-03 | $67.27M derived: sum of 3 quarters · filed 2024-02-22 | $84.46M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $20.35M 10-Q · filed 2023-05-04 | $39.78M derived: sum of 2 quarters · filed 2024-02-22 | $56.97M derived: sum of 3 quarters · filed 2024-02-22 | $74.60M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $19.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $36.62M derived: sum of 2 quarters · filed 2024-02-22 | $54.25M derived: sum of 3 quarters · filed 2024-02-22 | $68.42M 10-K · filed 2024-02-22 |
| 2021-09-30 | $17.20M 10-Q · filed 2022-11-03 | $34.83M derived: sum of 2 quarters · filed 2022-11-03 | $49.00M 10-Q · filed 2022-11-03 | $61.86M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $17.63M 10-Q · filed 2022-08-04 | $31.80M 10-Q · filed 2022-08-04 | $44.66M derived: sum of 3 quarters · filed 2023-02-23 | $56.27M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $14.17M 10-Q · filed 2022-04-29 | $27.03M derived: sum of 2 quarters · filed 2023-02-23 | $38.64M derived: sum of 3 quarters · filed 2023-02-23 | $44.94M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $12.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $24.47M derived: sum of 2 quarters · filed 2023-02-23 | $30.77M derived: sum of 3 quarters · filed 2023-02-23 | $40.90M 10-K · filed 2023-02-23 |
| 2020-09-30 | $11.61M 10-Q · filed 2021-11-04 | $17.91M derived: sum of 2 quarters · filed 2021-11-04 | $28.04M 10-Q · filed 2021-11-04 | $38.44M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $6.30M 10-Q · filed 2021-07-28 | $16.43M 10-Q · filed 2021-07-28 | $26.83M derived: sum of 3 quarters · filed 2022-02-24 | $36.98M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $10.13M 10-Q · filed 2021-05-04 | $20.52M derived: sum of 2 quarters · filed 2022-02-24 | $30.67M derived: sum of 3 quarters · filed 2022-02-24 | $41.62M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $10.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $20.54M derived: sum of 2 quarters · filed 2022-02-24 | $31.49M derived: sum of 3 quarters · filed 2022-02-24 | $41.89M 10-K · filed 2022-02-24 |
| 2019-09-30 | $10.15M 10-Q · filed 2020-11-05 | $21.10M derived: sum of 2 quarters · filed 2020-11-05 | $31.50M 10-Q · filed 2020-11-05 | $41.41M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $10.95M 10-Q · filed 2020-07-31 | $21.34M 10-Q · filed 2020-07-31 | $31.26M derived: sum of 3 quarters · filed 2021-02-25 | $41.73M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $10.40M 10-Q · filed 2020-04-30 | $20.31M derived: sum of 2 quarters · filed 2021-02-25 | $30.79M derived: sum of 3 quarters · filed 2021-02-25 | $42.92M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $9.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $20.39M derived: sum of 2 quarters · filed 2021-02-25 | $32.52M derived: sum of 3 quarters · filed 2021-02-25 | $43.16M 10-K · filed 2021-02-25 |
| 2018-09-30 | $10.48M 10-Q · filed 2019-10-31 | $22.61M derived: sum of 2 quarters · filed 2019-10-31 | $33.25M 10-Q · filed 2019-10-31 | $43.67M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $12.13M 10-Q · filed 2019-07-25 | $22.77M 10-Q · filed 2019-07-25 | $33.19M derived: sum of 3 quarters · filed 2020-02-25 | $43.27M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $10.64M 10-Q · filed 2019-04-30 | $21.06M derived: sum of 2 quarters · filed 2020-02-25 | $31.14M derived: sum of 3 quarters · filed 2020-02-25 | $42.74M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $10.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $20.50M derived: sum of 2 quarters · filed 2020-02-25 | $32.10M derived: sum of 3 quarters · filed 2020-02-25 | $42.31M 10-K · filed 2020-02-25 |
| 2017-09-30 | $10.07M 10-Q · filed 2018-10-30 | $21.68M derived: sum of 2 quarters · filed 2018-10-30 | $31.89M 10-Q · filed 2018-10-30 | $40.58M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-06-30 | $11.60M 10-Q · filed 2018-08-01 | $21.82M 10-Q · filed 2018-08-01 | $30.50M derived: sum of 3 quarters · filed 2019-02-20 | $39.21M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-03-31 | $10.21M 10-Q · filed 2018-05-02 | $18.90M derived: sum of 2 quarters · filed 2019-02-20 | $27.61M derived: sum of 3 quarters · filed 2019-02-20 | $37.45M derived: sum of 4 quarters · filed 2019-02-20 |
| 2016-12-31 | $8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $17.39M derived: sum of 2 quarters · filed 2019-02-20 | $27.23M derived: sum of 3 quarters · filed 2019-02-20 | $36.54M 10-K · filed 2019-02-20 |
| 2016-09-30 | $8.71M 10-Q · filed 2017-11-02 | $18.55M derived: sum of 2 quarters · filed 2017-08-01 | $27.86M 10-Q · filed 2017-11-02 | $35.66M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $9.84M 10-Q · filed 2017-08-01 | $19.15M 10-Q · filed 2017-08-01 | $26.96M derived: sum of 3 quarters · filed 2018-02-26 | $35.59M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $9.31M 10-Q · filed 2017-05-02 | $17.11M derived: sum of 2 quarters · filed 2018-02-26 | $25.75M derived: sum of 3 quarters · filed 2018-02-26 | $34.98M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $16.44M derived: sum of 2 quarters · filed 2018-02-26 | $25.67M derived: sum of 3 quarters · filed 2018-02-26 | $34.74M 10-K · filed 2018-02-26 |
| 2015-09-30 | $8.63M 10-Q · filed 2016-11-01 | $17.86M derived: sum of 2 quarters · filed 2016-11-01 | $26.93M 10-Q · filed 2016-11-01 | $34.82M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $9.23M 10-Q · filed 2016-08-04 | $18.30M 10-Q · filed 2016-08-04 | $26.19M derived: sum of 3 quarters · filed 2017-02-23 | $34.52M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $9.07M 10-Q · filed 2016-05-03 | $16.96M derived: sum of 2 quarters · filed 2017-02-23 | $25.29M derived: sum of 3 quarters · filed 2017-02-23 | $34.69M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $7.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $16.22M derived: sum of 2 quarters · filed 2017-02-23 | $25.62M derived: sum of 3 quarters · filed 2017-02-23 | $35.12M 10-K · filed 2017-02-23 |
| 2014-09-30 | $8.33M 10-Q · filed 2015-11-04 | $17.73M derived: sum of 2 quarters · filed 2015-11-04 | $27.23M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $9.40M 10-Q · filed 2015-08-05 | $18.90M 10-Q · filed 2015-08-05 | ||
| 2013-12-31 | $35.23M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |